Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CINACALCET HYDROCHLORIDE
- A Study of SHR6508 in Secondary Hyperparathyroidism
- Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
- Novel Combination Therapy for Osteoporosis in Men
- Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
- Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
- Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
- Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
- Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
- Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved?
- Phase 3 Study of KHK7580
- Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
- Renal Osteodystrophy: An Individual Management Approach
- Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
- Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
- Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
- Phase 2 Study of KHK7580
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis
- A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
- Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide
- Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
- Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
- Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects
- Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone System
- Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
- Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
- Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
- Pediatric Chronic Kidney Disease Safety and Efficacy
- Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients
- Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis
- Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
- Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism
- Evaluation of a Cincalcet Suppression Test
- Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level
- Trial to Optimize Mineral Outcomes in Dialysis Patients
- Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
- Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
- Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
- A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism
- A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)
- PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
- Calcimimetics in Hypophosphatemic Rickets
- 20070360 Incident Dialysis
- Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
- A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)
- Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
- ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
- E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
- The Effect of Cinacalcet on Gastric Acid Output in Healthy Subjects
- Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
- Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
- SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
- Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
- Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
- A Research Study for Patients With End-Stage Renal Disease (ESRD)
- Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Clinical trials list
click for details